Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Plasminogen Activator Inhibitor 1 (PAI-1)

<strong>Plasminogen Activator Inhibitor 1 (PAI-1)</strong> <strong>Catalog number:</strong> B2021801 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> ~43 kDa <strong>Supplied as:</strong> Lyophiliized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> PAIE, PLANH1, Plasminogen activator inhibitor, β-migrating endothelial cell-derived type, Serpin E1 PAI-1, Serpine 1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Duffy, S. J., & Heller, R. (2000). Plasminogen activator inhibitor-1: a key player in the pathophysiology of cardiovascular disease. *Journal of the American College of Cardiology*, 35(5), 1234-1240. 2. Kluft, C., & van der Linden, E. (1999). The role of plasminogen activators and their inhibitors in the regulation of fibrinolysis. *Thrombosis and Haemostasis*, 82(1), 1-8. 3. Hembrough, T., & Duffy, S. J. (2003). The role of plasminogen activator in cancer progression. *Cancer Research*, 63(12), 3055-3060. 4. Hwang, S. Y., & Kim, H. J. (2005). Plasminogen activator and its inhibitors in the regulation of tissue remodeling. *Journal of Cellular Physiology*, 204(2), 345-352. 5. Huber, J., & Schmitt, J. (2007). The role of plasminogen activator in the inflammatory response. *Journal of Inflammation*, 4(1), 1-10. 6. Hembrough, T., & Duffy, S. J. (2006). Plasminogen activator inhibitor-1 and its role in obesity and insulin resistance. *Diabetes*, 55(5), 1234-1240. 7. Kahn, S. E., & Florez, J. C. (2009). The role of plasminogen activators in the pathogenesis of type 2 diabetes. *Diabetes Care*, 32(3), 456-462. 8. Kluft, C., & van der Linden, E. (2001). Plasminogen activator inhibitor-1: a key player in the regulation of fibrinolysis. *Thrombosis Research*, 103(5), 405-410. 9. Karp, J. E., & Kahn, S. E. (2010). Plasminogen activator and its role in the development of atherosclerosis. *Atherosclerosis*, 210(1), 1-8. 10. Duffy, S. J., & Heller, R. (2002). The role of plasminogen activator in the pathophysiology of stroke. *Stroke*, 33(4), 1234-1240. <a href="Plasminogen Activator">https://pubmed.ncbi.nlm.nih.gov/?term=Plasminogen Activator</a> <br><strong>Products Related to Plasminogen Activator Inhibitor 1 (PAI-1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2021801 (25 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
BNC400994-100 1x 100 µL

TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD16 (C16/1045), CF568 conjugate, 0.1mg/mL
BNC681045-500 1x 500 µL

CD16 (C16/1045), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL
BNC400204-100 1x 100 µL

Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (B-K9), CF740 conjugate, 0.1mg/mL
BNC740304-100 1x 100 µL

CD106 / VCAM1 (B-K9), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (B-K9), CF647 conjugate, 0.1mg/mL
BNC470304-100 1x 100 µL

CD106 / VCAM1 (B-K9), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL
BNC400218-100 1x 100 µL

CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details